The different expression levels of PFKFB3 and PFK-1 among CSC, iPS cells and non-stem cancer cells suggest improved prospects for the more precise detection of CSCs and for clinical applications of stem cell-based therapies. This evidence concerns the gene PFKFB3 and cancer.